المؤلفون: Arron, Sarah, Chang, ALS, Arron, ST, Migden, MR, Solomon, JA, Yoo, S, Day, B-M, McKenna, EF, Sekulic, A

الوصول الحر: https://escholarship.org/uc/item/3qv5w0gcTest

المؤلفون: Arron, Sarah, Steenrod, AW, Smyth, EN, Bush, EN, Chang, ALS, Arron, ST, Helfrich, YR, Von, DD, Brail, LH, Coyne, KS

الوصول الحر: https://escholarship.org/uc/item/4zc46400Test

المؤلفون: Rischin, D, Khushalani, N, Schmults, CD, Guminski, A, Chang, ALS, Lewis, KD, Lim, AM, Hernandez-Aya, L, Hughes, BGM, Schadendorf, D, Hauschild, A, Thai, AA, Stankevich, E, Booth, J, Yoo, S-Y, Li, S, Chen, Z, Okoye, E, Chen, C, Mastey, V, Sasane, M, Lowy, I, Fury, MG, Migden, MR

العلاقة: pii: jitc-2021-002757; Rischin, D., Khushalani, N., Schmults, C. D., Guminski, A., Chang, A. L. S., Lewis, K. D., Lim, A. M., Hernandez-Aya, L., Hughes, B. G. M., Schadendorf, D., Hauschild, A., Thai, A. A., Stankevich, E., Booth, J., Yoo, S. -Y., Li, S., Chen, Z., Okoye, E., Chen, C. ,. Migden, M. R. (2021). Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9 (8), https://doi.org/10.1136/jitc-2021-002757Test.; http://hdl.handle.net/11343/287788Test

الإتاحة: https://doi.org/10.1136/jitc-2021-002757Test
http://hdl.handle.net/11343/287788Test

المؤلفون: Rischin, D, Migden, MR, Lim, AM, Schmults, CD, Khushalani, N, Hughes, BGM, Schadendorf, D, Dunn, LA, Hernandez-Aya, L, Chang, ALS, Modi, B, Hauschild, A, Ulrich, C, Eigentler, T, Stein, B, Pavlick, AC, Geiger, JL, Gutzmer, R, Alam, M, Okoye, E, Mathias, M, Jankovic, V, Stankevich, E, Booth, J, Li, S, Lowy, I, Fury, MG, Guminski, A

العلاقة: pii: jitc-2020-000775; Rischin, D., Migden, M. R., Lim, A. M., Schmults, C. D., Khushalani, N., Hughes, B. G. M., Schadendorf, D., Dunn, L. A., Hernandez-Aya, L., Chang, A. L. S., Modi, B., Hauschild, A., Ulrich, C., Eigentler, T., Stein, B., Pavlick, A. C., Geiger, J. L., Gutzmer, R., Alam, M. ,. Guminski, A. (2020). Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (1), https://doi.org/10.1136/jitc-2020-000775Test.; http://hdl.handle.net/11343/244754Test

الإتاحة: https://doi.org/10.1136/jitc-2020-000775Test
http://hdl.handle.net/11343/244754Test

المؤلفون: Pollom El, Bui Tt, Chang Als, Colevas Ad, Sekulic A, Oro Ae, Efficacy, Carcinoma. N Engl J Med, Strasswimmer J, Latimer B, Ory S. Amenorrhea, Fertil Steril, Ochoa B, Delgado I, Hedgehog

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://archderm.jamanetwork.com/data/Journals/DERM/934349/ded150002.pdfTest.

وصف الملف: application/pdf

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.698.4163Test; http://archderm.jamanetwork.com/data/Journals/DERM/934349/ded150002.pdfTest

الإتاحة: http://archderm.jamanetwork.com/data/Journals/DERM/934349/ded150002.pdfTest

المؤلفون: Migden, MR, Khushalani, NI, Chang, ALS, Lewis, KD, Schmults, CD, Hernandez-Aya, L, Meier, F, Schadendorf, D, Guminski, A, Hauschild, A, Wong, DJ, Daniels, GA, Berking, C, Jankovic, V, Stankevich, E, Booth, J, Li, S, Weinreich, DM, Yancopoulos, GD, Lowy, I, Fury, MG, Rischin, D

العلاقة: pii: S1470-2045(19)30728-4; Migden, M. R., Khushalani, N. I., Chang, A. L. S., Lewis, K. D., Schmults, C. D., Hernandez-Aya, L., Meier, F., Schadendorf, D., Guminski, A., Hauschild, A., Wong, D. J., Daniels, G. A., Berking, C., Jankovic, V., Stankevich, E., Booth, J., Li, S., Weinreich, D. M., Yancopoulos, G. D. ,. Rischin, D. (2020). Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. LANCET ONCOLOGY, 21 (2), pp.294-305. https://doi.org/10.1016/S1470-2045Test(19)30728-4.; http://hdl.handle.net/11343/273444Test

الإتاحة: https://doi.org/10.1016/S1470-2045Test(19)30728-4
http://hdl.handle.net/11343/273444Test